Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 13NIH 7NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Carcinoma, Renal Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Neoplasms 2Melanoma 2Warts 1Recurrence 1Papilloma 1Neoplasm Metastasis 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Kidney Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Imatinib Mesylate 15Dasatinib 14nilotinib 8olverembatinib 4asciminib 4ponatinib 3Cyclosporine 3bosutinib 2Methotrexate 2Homoharringtonine 2Cyclophosphamide 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2inecalcitol 1flumatinib 1fludarabine phosphate 1elsulfavirine 1Whole-Body Irradiation 1Transplantation 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1PF-114 1Mycophenolic Acid 1Interferon-alpha 1Hydroxyurea 1Fentanyl 1Everolimus 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Busulfan 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Myeloid, Chronic-Phase × Interferon-alpha × Clear all
NCT00006343 2013-01-03

STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Novartis

Phase 3 Completed
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡